Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
A recent study highlights the occurrence of anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease in patients treated with enfortumab vedotin and pembrolizumab for advanced urothelial carcinoma. This finding underscores the need for careful monitoring of lung-related adverse effects in this patient population.
Read full storyGet the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.